Post Reply
521-529 of 529
The 6.03% was during the private placement.
Founders of Skylight Abalone increased their shareholding to 6.03% of the enlarged share capital. The other strategic investor is renowned abalone restaurant in Asia, Ah Yat Abalone. Institutional investors include Dubai Investment Group, Guoco Group and Lehman Brothers.
TR Network has already been renamed Oceanus Bio-Tech.
Oceanus rose on talks that a new strategic investor may emerge.
Today close at higher px and higher vol.
Something is brewing,,,
Why TR so quiet, RTO will happen or not?
Dude, TR jumped 600% since last year. I'm pretty certain its been priced in already, Pilipala... Trade with caution
Do you think there is any more upside to the current share price or the current share price has factored in the acquisition?
Oceanus Bio-tech (OB) is a marine aquaculture specialist focusing on large-scale, land-based industrialised production and sale of high value live seafood with aquaculture facilities located in China?s Shandong and Fujian provinces. Incorporated in Singapore, Oceanus Bio-tech is the holding company of its wholly-owned operating subsidiary in China, Weihai Nanyang Biologic Technology Co., Ltd.
OB has more than 10 years track record in the R&D, genetic selection, intensive production and sale of high-value live seafood products, particularly Abalone,,Halibut and Turbot. Abalone, a seafood delicacy with the highest economic value among all farmed seafood products, currently constitutes approximately 80% of Oceanus Bio-tech?s business focus.
OB is one of the largest producers of very high grade Abalone (Japanese sub-species) in China, if not in Asia. With its own specialized formulated feeds and large- scale production, it has a low cost advantage among the producers.
OB is targeting to become an integrated premium seafood products provider in the next few years by extending the value chain into downstream processing activities such as developing and producing frozen, canned and dried premium seafood products.
It has proposed an RTO of Oceanus Bio-Tech (OB). It will issue 1.35b new shares at $0.20 each.
Best Global, a controlling shareholder of OB, agrees to warrant that the NPAT of OB for FY07 shall not be less than RMB150m.